Madrigal Pharmaceuticals, Inc. (MDGL)
513.21
+0.19
(+0.04%)
USD |
NASDAQ |
Sep 24, 16:00
513.10
-0.11
(-0.02%)
Pre-Market: 19:59
Madrigal Pharmaceuticals Gross Profit (Annual) : 900.75M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 900.75M |
| December 31, 2024 | 172.80M |
| December 31, 2023 | -0.527M |
| December 31, 2022 | -0.467M |
| December 31, 2021 | -0.405M |
| December 31, 2020 | -0.471M |
| December 31, 2019 | -0.112M |
| December 31, 2018 | -0.096M |
| December 31, 2017 | -0.077M |
| December 31, 2016 | -0.0002M |
| December 31, 2015 | 0.00 |
| December 31, 2014 | -0.673M |
| Date | Value |
|---|---|
| December 31, 2013 | -0.516M |
| December 31, 2012 | -0.738M |
| December 31, 2011 | 6.12M |
| December 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | -3.655M |
| December 31, 2005 | 0.00 |
| December 31, 2004 | -2.957M |
| December 31, 2003 | 0.298M |
| December 31, 2002 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Exelixis, Inc. | 2.236B |
| Insmed, Inc. | 477.48M |
| United Therapeutics Corp. | 2.798B |
| Karyopharm Therapeutics, Inc. | 139.82M |